Associated Papers
Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.
Walsh RJ et al.
Frontiers in Oncology, 2024
38812774 (PubMed )
Supplement: DataSheet_2.xlsx › Sheet1
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population.
Huang Q et al.
Bmc Medical Genomics, 2022
Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer.
G V et al.
Frontiers in Genetics, 2022
36561320 (PubMed )
Supplement: Table3.xlsx › Sheet1
Next-generation sequencing-based identification of EGFR and NOTCH2 complementary mutations in non-small cell lung cancer.
Niu L et al.
Oncology Letters, 2021
Molecular profile of Hürthle cell carcinomas: recurrent mutations in the Wnt/β-catenin pathway.
Santana NO et al.
European Journal of Endocrinology, 2020
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach.
Manca A et al.
Journal of Translational Medicine, 2019
31455347 (PubMed )
Supplement: 12967_2019_2039_MOESM1_ESM.xlsx › Discovery_cohort_nsyn_variants
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
Kim HJ et al.
International Journal of Cancer, 2018
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.
Heong V et al.
International Journal of Cancer, 2018
Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
Teng L et al.
Oncotarget, 2017
28423545 (PubMed )
Supplement: oncotarget-08-22023-s003.xls › ___3
Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability.
Li X et al.
Cancer Research, 2016
Select a paper to view details